EUVIMEDEUVIMED entdecken
Crossref

Uterine bleeding in breast cancer patients: Insights from a 5-year institutional review

Aishwarya Sharma, Tanisha Singla, Prabhat Ganju, Rahatdeep Singh Brar, Puneet Kaur Somal, Nilay Nishith, Ravikiran Narayansing Pawar, Rahul Raj, Sankalp Sancheti, Gunjan Baijal, Sahil Mittal, Seema Gulia

South Asian Journal of Cancer · 18.05.2026 · 15 · 36-43

DOI: 10.25259/sajc_34_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift South Asian Journal of Cancer, online erschienen am 18.05.2026. Verfasst von Aishwarya Sharma und 11 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Uterine bleeding is an infrequent symptom in breast carcinoma patients, primarily linked to Tamoxifen therapy and less commonly to secondary malignancies or metastatic spread. The objective of this study was to ascertain the aetiology of uterine bleeding within a 5-year cohort of breast carcinoma patients. Material and Methods: A retrospective analysis included breast carcinoma patients who underwent endometrial or cervical biopsy for the evaluation of uterine bleeding were included in the review. All histology slides and radiology scans were meticulously reviewed. Patient clinical details were documented through the electronic medical records. Categorical variables were presented as frequencies and percentages. All statistical analyses were performed on SPSS.

Results

Among the 4,543 breast carcinoma patients registered at our tertiary care oncology centre, only 45 patients (0.9%) underwent endometrial/cervix biopsy for pathologies in the gynaecological tract. Uterine bleeding was the most common indication, accounting for 29/45 (64.4%) cases, predominance attributed to structural causes according to the PALM-COEIN classification. Malignancies and premalignant lesions were detected in the majority of cases, comprising 37.7% of the cohort, while benign endometrial polyps represented the second most at 31%.

Conclusion

These results highlight the critical necessity for comprehensive patient education and implementation of rigorous surveillance protocols to monitor uterine pathologies within this patient population.

Zitieren

APA

Sharma, A., Singla, T., Ganju, P., Brar, R. S., Somal, P. K., Nishith, N., Pawar, R. N., Raj, R., Sancheti, S., Baijal, G., Mittal, S., & Gulia, S. (2026). Uterine bleeding in breast cancer patients: Insights from a 5-year institutional review. South Asian Journal of Cancer, 15, 36-43. https://doi.org/10.25259/sajc_34_2025

Vancouver

Sharma A, Singla T, Ganju P, Brar RS, Somal PK, Nishith N, et al. Uterine bleeding in breast cancer patients: Insights from a 5-year institutional review. South Asian Journal of Cancer. 2026;15:36-43. doi:10.25259/sajc_34_2025

BibTeX
@article{Sharma2026,
  author = {Sharma, Aishwarya and Singla, Tanisha and Ganju, Prabhat and Brar, Rahatdeep Singh and Somal, Puneet Kaur and Nishith, Nilay and Pawar, Ravikiran Narayansing and Raj, Rahul and Sancheti, Sankalp and Baijal, Gunjan and Mittal, Sahil and Gulia, Seema},
  title = {Uterine bleeding in breast cancer patients: Insights from a 5-year institutional review},
  journal = {South Asian Journal of Cancer},
  year = {2026},
  volume = {15},
  pages = {36--43},
  doi = {10.25259/sajc_34_2025}
}
Kostenlos starten →